Impact of obesity on atrial fibrillation ablation.

Ablation Techniques / adverse effects Adiposity Animals Atrial Fibrillation / diagnosis Body Mass Index Heart Rate Humans Obesity / diagnosis Risk Factors Treatment Outcome Weight Gain
Ablation de fibrillation atriale Atrial fibrillation ablation Obesity Obésité Tissu adipeux épicardique

Journal

Archives of cardiovascular diseases
ISSN: 1875-2128
Titre abrégé: Arch Cardiovasc Dis
Pays: Netherlands
ID NLM: 101465655

Informations de publication

Date de publication:
Historique:
received: 21 01 2020
revised: 07 03 2020
accepted: 11 03 2020
pubmed: 6 8 2020
medline: 30 9 2020
entrez: 6 8 2020
Statut: ppublish

Résumé

Obesity is a major risk factor for atrial fibrillation. It also influences the natural history of the disease, leading to more persistent forms and poorer ablation outcomes. This article reviews atrial fibrillation ablation in the obese population, focusing on outcomes, complications and periprocedural management. Through an analysis of the possible pathophysiological mechanism linking obesity and atrial fibrillation, we identify potential strategies to improve post-ablation outcomes in this challenging population.

Identifiants

DOI: 10.1016/j.acvd.2020.03.023 PMID: 32753124
pubmed: 32753124
pii: S1875-2136(20)30144-3
doi: 10.1016/j.acvd.2020.03.023
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

551-563

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Valentina Mangiafico (V)

Department of Cardiovascular, Respiratory, Nephrological, Anaesthesiological and Geriatric Sciences, "Sapienza" University of Rome, Policlinico Umberto I, 00161 Rome, Italy.

Bunny Saberwal (B)

Barts Heart Centre, West Smithfield, London EC1A 7BE, United Kingdom. Electronic address: bunny.saberwal@nhs.net.

Carlo Lavalle (C)

Department of Cardiovascular, Respiratory, Nephrological, Anaesthesiological and Geriatric Sciences, "Sapienza" University of Rome, Policlinico Umberto I, 00161 Rome, Italy.

Antony Raharja (A)

Barts Heart Centre, West Smithfield, London EC1A 7BE, United Kingdom.

Zuhair Ahmed (Z)

Queen-Mary University of London, London E1 4NS, United Kingdom.

Nikos Papageorgiou (N)

Institute of Cardiovascular Sciences, University College London, London WC1E 6DD, United Kingdom.

Syed Ahsan (S)

Barts Heart Centre, West Smithfield, London EC1A 7BE, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Procédures de chirurgie opératoire › Techniques d'ablation › Impact of obesity on atrial fibrillation ablation.
questionsmedicales.fr › Phénomènes physiologiques › Constitution physique › Composition corporelle › Répartition du tissu adipeux › Adiposité › Impact of obesity on atrial fibrillation ablation.
questionsmedicales.fr › Eucaryotes › Animaux › Impact of obesity on atrial fibrillation ablation.
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Troubles du rythme cardiaque › Fibrillation auriculaire › Impact of obesity on atrial fibrillation ablation.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Biométrie › Anthropométrie › Indice de masse corporelle › Impact of obesity on atrial fibrillation ablation.
questionsmedicales.fr › Phénomènes physiologiques respiratoires et circulatoires › Phénomènes physiologiques cardiovasculaires › Hémodynamique › Rythme cardiaque › Impact of obesity on atrial fibrillation ablation.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Impact of obesity on atrial fibrillation ablation.
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Obésité › Impact of obesity on atrial fibrillation ablation.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Impact of obesity on atrial fibrillation ablation.
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Impact of obesity on atrial fibrillation ablation.
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Mensurations corporelles › Poids › Modifications du poids corporel › Prise de poids › Impact of obesity on atrial fibrillation ablation.